VisionGate’s Cell-CT™ 3D Cellular Imaging Platform Detects the Presence of Cancer-Associated Cells (CACs) that have undergone Malignancy Associated Change (MAC)

World News: . []

SEATTLE WA April 16 2018 GLOBE NEWSWIRE -- VisionGate a clinical stage oncology pharmaceutical and diagnostics company today presented a breakthrough research study demonstrated its Cell-CT platform can detect subtle changes in cellular and nuc...

More news and information about VisionGate, Inc.

Published By:

Globe Newswire: 14:23 GMT Monday 16th April 2018

Published: .

Search for other references to "visiongate" on SPi News


Share

Previous StoryNext Story

SPi News is published by Sector Publishing Intelligence Ltd.
© Sector Publishing Intelligence Ltd 2018. [Admin Only]
 
Sector Publishing Intelligence Ltd.
Agriculture House, Acland Road, DORCHESTER, Dorset DT1 1EF United Kingdom
Registered in England and Wales number 0751938.
 
Privacy Policy | Terms and Conditions | Contact Us